ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MXC Mgc Pharmaceuticals Limited

22.00
1.00 (4.76%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Mgc Pharmaceuticals Limited LSE:MXC London Ordinary Share AU000000MXC6 ORD NPV (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.00 4.76% 22.00 21.00 23.00 23.00 21.00 21.00 20,732 11:40:24
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Drug & Proprietary Stores 4.16M -20.82M -0.4749 -0.86 17.98M

MGC Pharmaceuticals Limited Director/PDMR Shareholding (6092R)

09/03/2021 7:00am

UK Regulatory


Mgc Pharmaceuticals (LSE:MXC)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Mgc Pharmaceuticals Charts.

TIDMMXC

RNS Number : 6092R

MGC Pharmaceuticals Limited

09 March 2021

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

 
Name of entity MGC Pharmaceuticals Limited 
ABN 30 116 800 269 
 

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

 
 Name of Director                                Stephen Barry Parker 
              Date of last notice                13 March 2019 
                                   ---------------------------------- 
 

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

 
              Direct or indirect              Indirect 
               interest 
              Nature of indirect              Held through a UK Individual Savings 
               interest                        Account ("ISA") 
               (including registered 
               holder)                         Registered Holder is Barclays Bank PLC 
               Note: Provide details 
               of the circumstances 
               giving rise to the 
               relevant interest. 
                                             ---------------------------------------- 
              Date of change                               5 March 2021 
                                             ---------------------------------------- 
              No. of securities held                       Nil 
               prior to change 
                                             ---------------------------------------- 
              Class                                        Ordinary shares 
                                             ---------------------------------------- 
              Number acquired                              282,316 
                                             ---------------------------------------- 
              Number disposed                              - 
                                             ---------------------------------------- 
              Value/Consideration                          GBP 9,999.99 
               Note: If consideration 
               is non-cash, provide 
               details and estimated 
               valuation 
                                             ---------------------------------------- 
              No. of securities held                       282,316 ordinary shares 
               after change 
                                             ---------------------------------------- 
              Nature of change                             On-market trade 
               Example: on-market 
               trade, off-market trade, 
               exercise of options, 
               issue of securities 
               under dividend reinvestment 
               plan, participation 
               in buy-back 
                                             ---------------------------------------- 
 

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

 
              Detail of contract                            N/A 
              Nature of interest 
                                                           ---- 
              Name of registered holder 
               (if issued securities) 
                                                           ---- 
              Date of change 
                                                           ---- 
              No. and class of securities to which 
               interest related prior to change 
               Note: Details are only required for 
               a contract in relation to which the 
               interest has changed 
                                                           ---- 
              Interest acquired 
                                                           ---- 
              Interest disposed 
                                                           ---- 
              Value/Consideration 
               Note: If consideration is non-cash, 
               provide details and an estimated valuation 
                                                           ---- 
              Interest after change 
                                                           ---- 
 

Part 3 - + Closed period

 
              Were the interests in the securities       No 
               or contracts detailed above traded 
               during a + closed period where prior 
               written clearance was required? 
              If so, was prior written clearance 
               provided to allow the trade to proceed 
               during this period? 
                                                        --- 
              If prior written clearance was provided, 
               on what date was this provided? 
                                                        --- 
 

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

 
Name of entity MGC Pharmaceuticals Limited 
ABN 30 116 800 269 
 

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

 
 Name of Director                                Brett Anthony Mitchell 
              Date of last notice                12 August 2020 
                                   ------------------------------------ 
 

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

 
              Direct or indirect              Indirect 
               interest 
              Nature of indirect                           Brett and Michelle Mitchell <Mitchell 
               interest                                     Spring Family A/C> 
               (including registered                        Trustee 
               holder)                                      Brett and Michelle Mitchell <Lefthanders 
               Note: Provide details                        Super Fund A/C> 
               of the circumstances                         Trustee 
               giving rise to the 
               relevant interest. 
                                             ------------------------------------------------------- 
              Date of change                               5 March 2021 
                                             ------------------------------------------------------- 
              No. of securities held                       Brett and Michelle Mitchell <Mitchell 
               prior to change                              Spring Family A/C> 
                                                            22,264,444 Fully Paid Ordinary Shares 
                                                            3,750,000 Performance Rights 
                                                            277,777 Listed Options exercisable at 
                                                            $0.045 each expiring 31 August 2021 
 
                                                            Brett and Michelle Mitchell <Lefthanders 
                                                            Super Fund A/C> 
                                                            8,140,560 Fully Paid Ordinary Shares 
                                                            3,750,000 Performance Rights 
                                                            277,777 Listed Options exercisable at 
                                                            $0.045 each expiring 31 August 2021 
 
                                                            Chieftain Securities Pty Ltd 
                                                            5,000,000 Unlisted Options exercisable 
                                                            at $0.15 expiring 30 June 2021 
                                                            1,500,000 Unlisted Options exercisable 
                                                            at $0.05 expiring 31 August 2023 
                                                            1,500,000 Unlisted Options exercisable 
                                                            at $0.06 expiring 31 August 2023 
                                                            1,500,000 Unlisted Options exercisable 
                                                            at $0.07 expiring 31 August 2023 
                                             ------------------------------------------------------- 
              Class                                        Performance Rights 
                                             ------------------------------------------------------- 
              Number acquired                              Nil 
                                             ------------------------------------------------------- 
              Number disposed                              2,500,000 
                                             ------------------------------------------------------- 
              Value/Consideration                          Nil - Cancellation of performance rights 
               Note: If consideration 
               is non-cash, provide 
               details and estimated 
               valuation 
                                             ------------------------------------------------------- 
              No. of securities held                       Brett and Michelle Mitchell <Mitchell 
               after change                                 Spring Family A/C> 
                                                            22,264,444 Fully Paid Ordinary Shares 
                                                            2,500,000 Performance Rights 
                                                            277,777 Listed Options exercisable at 
                                                            $0.045 each expiring 31 August 2021 
 
                                                            Brett and Michelle Mitchell <Lefthanders 
                                                            Super Fund A/C> 
                                                            8,140,560 Fully Paid Ordinary Shares 
                                                            2,500,000 Performance Rights 
                                                            277,777 Listed Options exercisable at 
                                                            $0.045 each expiring 31 August 2021 
 
                                                            Chieftain Securities Pty Ltd 
                                                            5,000,000 Unlisted Options exercisable 
                                                            at $0.15 expiring 30 June 2021 
                                                            1,500,000 Unlisted Options exercisable 
                                                            at $0.05 expiring 31 August 2023 
                                                            1,500,000 Unlisted Options exercisable 
                                                            at $0.06 expiring 31 August 2023 
                                                            1,500,000 Unlisted Options exercisable 
                                                            at $0.07 expiring 31 August 2023 
                                             ------------------------------------------------------- 
              Nature of change                             Cancellation of performance shares due 
               Example: on-market                           to performance conditions lapsing. 
               trade, off-market trade, 
               exercise of options, 
               issue of securities 
               under dividend reinvestment 
               plan, participation 
               in buy-back 
                                             ------------------------------------------------------- 
 

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

 
              Detail of contract                            N/A 
              Nature of interest 
                                                           ---- 
              Name of registered holder 
               (if issued securities) 
                                                           ---- 
              Date of change 
                                                           ---- 
              No. and class of securities to which 
               interest related prior to change 
               Note: Details are only required for 
               a contract in relation to which the 
               interest has changed 
                                                           ---- 
              Interest acquired 
                                                           ---- 
              Interest disposed 
                                                           ---- 
              Value/Consideration 
               Note: If consideration is non-cash, 
               provide details and an estimated valuation 
                                                           ---- 
              Interest after change 
                                                           ---- 
 

Part 3 - + Closed period

 
              Were the interests in the securities       No 
               or contracts detailed above traded 
               during a + closed period where prior 
               written clearance was required? 
              If so, was prior written clearance 
               provided to allow the trade to proceed 
               during this period? 
                                                        --- 
              If prior written clearance was provided, 
               on what date was this provided? 
                                                        --- 
 

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

 
Name of entity MGC Pharmaceuticals Limited 
ABN 30 116 800 269 
 

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

 
 Name of Director                                Roby Reuven Zomer 
              Date of last notice                12 August 2020 
                                   ------------------------------- 
 

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

 
              Direct or indirect interest             Indirect 
              Nature of indirect interest                          Chitta Lu Limited (Director 
               (including registered holder)                        and sole shareholder) 
               Note: Provide details of the 
               circumstances giving rise to 
               the relevant interest. 
                                                     -------------------------------------------------- 
              Date of change                                       5 March 2021 
                                                     -------------------------------------------------- 
              No. of securities held prior                         Chitta Lu Limited 
               to change                                            3,000,001 Fully Paid Ordinary 
                                                                    Shares 
                                                                    7,500,000 Performance Rights 
 
                                                                    HSBC Custody Nominees (Australia) 
                                                                    Limited 
                                                                    30,000,000 Fully Paid Ordinary 
                                                                    Shares 
                                                     -------------------------------------------------- 
              Class                                                Performance Rights 
                                                     -------------------------------------------------- 
              Number acquired                                      Nil 
                                                     -------------------------------------------------- 
              Number disposed                         2,500,000 Performance Rights 
                                                     -------------------------------------------------- 
              Value/Consideration                                  Non-cash - forfeited due to 
               Note: If consideration is non-cash,                  not meeting performance conditions. 
               provide details and estimated 
               valuation 
                                                     -------------------------------------------------- 
              No. of securities held after                         Chitta Lu Limited 
               change                                               3,000,001 Fully Paid Ordinary 
                                                                    Shares 
                                                                    5,000,000 Performance Rights 
 
                                                                    HSBC Custody Nominees (Australia) 
                                                                    Limited 
                                                                    30,000,000 Fully Paid Ordinary 
                                                                    Shares 
                                                     -------------------------------------------------- 
              Nature of change                                     Cancellation of performance 
               Example: on-market trade, off-market                 rights due to performance 
               trade, exercise of options,                          conditions lapsing 
               issue of securities under dividend 
               reinvestment plan, participation 
               in buy-back 
                                                     -------------------------------------------------- 
 

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

 
              Detail of contract                            N/A 
              Nature of interest 
                                                           ---- 
              Name of registered holder 
               (if issued securities) 
                                                           ---- 
              Date of change 
                                                           ---- 
              No. and class of securities to which 
               interest related prior to change 
               Note: Details are only required for 
               a contract in relation to which the 
               interest has changed 
                                                           ---- 
              Interest acquired 
                                                           ---- 
              Interest disposed 
                                                           ---- 
              Value/Consideration 
               Note: If consideration is non-cash, 
               provide details and an estimated valuation 
                                                           ---- 
              Interest after change 
                                                           ---- 
 

Part 3 - + Closed period

 
              Were the interests in the securities       N/A 
               or contracts detailed above traded 
               during a + closed period where prior 
               written clearance was required? 
              If so, was prior written clearance 
               provided to allow the trade to proceed 
               during this period? 
                                                        ---- 
              If prior written clearance was provided, 
               on what date was this provided? 
                                                        ---- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHGLGDXIXGDGBC

(END) Dow Jones Newswires

March 09, 2021 02:00 ET (07:00 GMT)

1 Year Mgc Pharmaceuticals Chart

1 Year Mgc Pharmaceuticals Chart

1 Month Mgc Pharmaceuticals Chart

1 Month Mgc Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock